← back to search

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

view on congress.gov

Policy area: Health

Latest action 2025-03-05 · Referred to the House Committee on Energy and Commerce. · showing text version Introduced in House of 2025-03-05T05:00:00Z

Sponsor

Rep. Dunn, Neal P. [R-FL-2] (R-FL)

1 cosponsor

Recent actions

• 2025-03-05 — Referred to the House Committee on Energy and Commerce.
• 2025-03-05 — Introduced in House

Subjects

None recorded.

Related bills

• Lower Costs for Everyday Americans Act
• Consolidated Appropriations Act, 2026
• Increasing Transparency in Generic Drug Applications Act
• Bipartisan Health Care Act

Text sections (3 indexed passages)

• 1.